Picard Medical, Inc. announced that the underwriters of its initial public offering exercised their over-allotment option in full, resulting in the issuance of additional shares.
The over-allotment option was exercised on September 5, 2025, leading to gross proceeds of $2,550,000.
Shares of Picard Medical began trading on NYSE American under the ticker symbol PMI on August 29, 2025.
Additional Share Issuance
637,500 additional shares of Common Stock were issued through the over-allotment option.
Offering Gross Proceeds
The additional shares generated gross proceeds of $2,550,000 before deducting expenses.
Trading Commencement
Shares of Picard Medical started trading on NYSE American on August 29, 2025.
- The exercise of the over-allotment option indicates strong investor demand for Picard Medical's Common Stock.
- The gross proceeds from the additional share issuance provide the company with added capital for its operations and growth initiatives.
Picard Medical's successful exercise of the over-allotment option underscores market confidence in the company's potential and growth prospects.